These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 28847625

  • 21. Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort.
    Blanchard G, Lafforgue MP, Lion-François L, Kemlin I, Rodriguez D, Castelnau P, Carneiro M, Meyer P, Rivier F, Barbarot S, Chaix Y, NF France network.
    Eur J Paediatr Neurol; 2016 Mar; 20(2):275-281. PubMed ID: 26774135
    [Abstract] [Full Text] [Related]

  • 22. Long-term outcome in children with gliomas of the anterior visual pathway.
    Tow SL, Chandela S, Miller NR, Avellino AM.
    Pediatr Neurol; 2003 Apr; 28(4):262-70. PubMed ID: 12849878
    [Abstract] [Full Text] [Related]

  • 23. Orbital optic nerve gliomas in children with neurofibromatosis type 1.
    Zeid JL, Charrow J, Sandu M, Goldman S, Listernick R.
    J AAPOS; 2006 Dec; 10(6):534-9. PubMed ID: 17189147
    [Abstract] [Full Text] [Related]

  • 24. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.
    Trevisson E, Cassina M, Opocher E, Vicenzi V, Lucchetta M, Parrozzani R, Miglionico G, Mardari R, Viscardi E, Midena E, Clementi M.
    J Neurooncol; 2017 Sep; 134(2):279-287. PubMed ID: 28577031
    [Abstract] [Full Text] [Related]

  • 25. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.
    Listernick R, Ferner RE, Liu GT, Gutmann DH.
    Ann Neurol; 2007 Mar; 61(3):189-98. PubMed ID: 17387725
    [Abstract] [Full Text] [Related]

  • 26. Isolated optic nerve gliomas: a multicenter historical cohort study.
    Shofty B, Ben-Sira L, Kesler A, Jallo G, Groves ML, Iyer RR, Lassaletta A, Tabori U, Bouffet E, Thomale UW, Hernáiz Driever P, Constantini S, Isolated Optic Nerve Abnormalities (IONA) Collaboration.
    J Neurosurg Pediatr; 2017 Dec; 20(6):549-555. PubMed ID: 28984541
    [Abstract] [Full Text] [Related]

  • 27. Pretreatment Endocrine Disorders Due to Optic Pathway Gliomas in Pediatric Neurofibromatosis Type 1: Multicenter Study.
    Santoro C, Perrotta S, Picariello S, Scilipoti M, Cirillo M, Quaglietta L, Cinalli G, Cioffi D, Di Iorgi N, Maghnie M, Gallizia A, Parpagnoli M, Messa F, De Sanctis L, Vannelli S, Marzuillo P, Miraglia Del Giudice E, Grandone A.
    J Clin Endocrinol Metab; 2020 Jun 01; 105(6):. PubMed ID: 32294191
    [Abstract] [Full Text] [Related]

  • 28. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas.
    Avery RA, Bouffet E, Packer RJ, Reginald A.
    Invest Ophthalmol Vis Sci; 2013 Feb 05; 54(2):1034-8. PubMed ID: 23329671
    [Abstract] [Full Text] [Related]

  • 29. Manifestations and Treatment of Adult-onset Symptomatic Optic Pathway Glioma in Neurofibromatosis Type 1.
    Mehlan J, Schüttauf F, Salamon JM, Kordes U, Friedrich RE, Mautner VF.
    Anticancer Res; 2019 Feb 05; 39(2):827-831. PubMed ID: 30711963
    [Abstract] [Full Text] [Related]

  • 30. Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.
    Freret ME, Gutmann DH.
    J Neurosci Res; 2019 Jan 05; 97(1):45-56. PubMed ID: 29704429
    [Abstract] [Full Text] [Related]

  • 31. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P, Opocher E, Pinello ML, Calderone M, Viscardi E, Clementi M, Battistella PA, Laverda AM, Da Dalt L, Perilongo G.
    Neuro Oncol; 2007 Oct 05; 9(4):430-7. PubMed ID: 17704361
    [Abstract] [Full Text] [Related]

  • 32. Optic pathway glioma of childhood.
    Rasool N, Odel JG, Kazim M.
    Curr Opin Ophthalmol; 2017 May 05; 28(3):289-295. PubMed ID: 28257299
    [Abstract] [Full Text] [Related]

  • 33. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.
    Chang BC, Mirabella G, Yagev R, Banh M, Mezer E, Parkin PC, Westall CA, Buncic JR.
    Invest Ophthalmol Vis Sci; 2007 Jun 05; 48(6):2895-902. PubMed ID: 17525226
    [Abstract] [Full Text] [Related]

  • 34. Natural history and outcome of optic pathway gliomas in children.
    Nicolin G, Parkin P, Mabbott D, Hargrave D, Bartels U, Tabori U, Rutka J, Buncic JR, Bouffet E.
    Pediatr Blood Cancer; 2009 Dec 15; 53(7):1231-7. PubMed ID: 19621457
    [Abstract] [Full Text] [Related]

  • 35. Late-onset optic pathway tumors in children with neurofibromatosis 1.
    Listernick R, Ferner RE, Piersall L, Sharif S, Gutmann DH, Charrow J.
    Neurology; 2004 Nov 23; 63(10):1944-6. PubMed ID: 15557519
    [Abstract] [Full Text] [Related]

  • 36. Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study.
    Henning AM, Handrup MM, Kjeldsen SM, Larsen DA, Ejerskov C.
    Orphanet J Rare Dis; 2021 Nov 22; 16(1):489. PubMed ID: 34809690
    [Abstract] [Full Text] [Related]

  • 37. Syndromic and sporadic pediatric optic pathway gliomas: review of clinical and histopathological differences and treatment implications.
    Shamji MF, Benoit BG.
    Neurosurg Focus; 2007 Nov 22; 23(5):E3. PubMed ID: 18004965
    [Abstract] [Full Text] [Related]

  • 38. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
    Byrne S, Connor S, Lascelles K, Siddiqui A, Hargrave D, Ferner RE.
    J Neurooncol; 2017 Jul 22; 133(3):609-614. PubMed ID: 28593402
    [Abstract] [Full Text] [Related]

  • 39. Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1.
    de Blank PM, Berman JI, Liu GT, Roberts TP, Fisher MJ.
    Neuro Oncol; 2013 Aug 22; 15(8):1088-95. PubMed ID: 23658320
    [Abstract] [Full Text] [Related]

  • 40. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.
    Sharif S, Ferner R, Birch JM, Gillespie JE, Gattamaneni HR, Baser ME, Evans DG.
    J Clin Oncol; 2006 Jun 01; 24(16):2570-5. PubMed ID: 16735710
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.